glp-1 and vision changes Zepbound Blindness Lawsuit [2026 Update] Ozempic GLP-1 NAION Vision Loss
Description
In the PKC pathway, dihydrosphingosine 1-phosphate (DHPSIP) organises phosphatidylinositol 3-kinase (PI3K) and eventually activates MAPKs, NFB and several mediators of inflammation that increase ROS production, alter gene expression [40]
![glp-1 and vision changes Zepbound Blindness Lawsuit [2026 Update] Ozempic GLP-1 NAION Vision Loss](https://injurylawsuitconnect.com/wp-content/uploads/2025/08/Ozempic-Mounjaro-Wegovy-Rybelsus-GLP-1-NAION-Eye-Injury-Vision-Loss-Lawsuit-Cases-and-Settlement-Claims.jpg)
Studies show that compounded GLP-1 therapy patients may experience an average of 20% reduction in overall body weight in a little over a year
![glp-1 and vision changes Zepbound Blindness Lawsuit [2026 Update] Ozempic GLP-1 NAION Vision Loss](https://cdn2.psychologytoday.com/assets/styles/article_inline_full_caption/public/field_blog_entry_images/2026-07/glp-1_vision_map_0.png.jpg?itok=9zKhbIVG)
Insurance policies change frequently and vary by plan
This is an off label strategy and differs from spacing doses or tapering because it includes time completely off treatment
![glp-1 and vision changes Zepbound Blindness Lawsuit [2026 Update] Ozempic GLP-1 NAION Vision Loss](https://pbs.twimg.com/media/HHoYEbIWwAYowtS.jpg)